Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-27T08:58:53.549Z Has data issue: false hasContentIssue false

Management of Parkinson’s disease challenged by co-morbid drug abuse

Published online by Cambridge University Press:  01 September 2022

J. Simas*
Affiliation:
Centro Hospitalar do Tâmega e Sousa, Department Of Psychiatry And Mental Health, Penafiel, Portugal
A. Delgado
Affiliation:
Unidade Local de Saúde de Matosinhos, Department Of Mental Health, Matosinhos, Portugal
R. Guedes
Affiliation:
Centro Hospitalar de Leiria, Department Of Mental Health And Psychiatry, Leiria, Portugal
C. Silveira
Affiliation:
Centro Hospitalar Universitário de São João, EPE, Department Of Psychiatry, Porto, Portugal Medical Faculty of Porto University, Department Of Clinic Neurosciences And Mental Health, Porto, Portugal
C. Soares
Affiliation:
Medical Faculty of Porto University, Department Of Clinic Neurosciences And Mental Health, Porto, Portugal Centro Hospitalar Universitário de São João, EPE, Department Of Neurology, Porto, Portugal
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Parkinson’s disease (PD) is a neurologic degenerative condition with complex neuropsychiatric manifestations which can be challenging to manage and greatly impact quality of life and prognosis.

Objectives

The description of this case aims to highlight the complex interaction between PD, drug-abuse and impulse control disorder (ICD).

Methods

Clinical information was obtained through patient interviewing and medical records consulting. A literature review on the topic was conducted.

Results

We report the case of a 52-years-old male with PD diagnosed at the age of 45, presenting with rigidity of right limbs and freezing of gait. He had a history of multiple substance-abuse: hashish, heroin and cocaine, with cessation of all substances by the age of 40. The patient responded well to antiparkinsonian medication initially, but needed frequent adjustments and developed ICD secondary to dopamine agonists, presenting pathological gambling and hypersexuality. At 47 he restarted using cocaine stating that it diminished the motor symptoms. Motor symptoms worsened and became partially responsive to medication. Pharmacologic options were limited due to ICD. He developed dopamine dysregulation syndrome, abusing dopaminergic drugs and requesting multiple prescriptions. Deep brain stimulation surgery was proposed, but the patient was deemed unfit for the procedure after two separate psychiatric evaluations, mainly because of behaviour and social problems in relation to sustained cocaine abuse and personality disorder. Attempts to stop drug abuse were unsuccessful despite several interventions by addiction psychiatry.

Conclusions

Co-occurrence of PD, substance-abuse and personality disorder poses as a therapeutic challenge conditioned by pharmacological iatrogenesis and behavioural disturbances, requiring a multidisciplinary and individualized approach.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.